文献速递乳腺癌放疗

老年早期乳腺癌放疗使用与健康相关生活质量及死亡率观察性队列研究

Observational cohort study in older women with early breast cancer: Use of radiation therapy and impact on health-related quality of life and mortality.
PubMed 文献 · Radiother Oncol · 2021-06-17

该多中心观察性研究纳入2013-2018年56个英国中心的2811例≥70岁早期乳腺癌术后患者,中位随访52个月。多因素分析显示年龄和肿瘤风险预测放疗使用,老年评估参数影响有限;健康相关生活质量影响(乳房症状、疲劳)在18个月内消退。

要点

  • 年龄和肿瘤复发风险预测老年早期乳腺癌患者放疗使用,老年评估参数影响有限。
  • 健康老年高危肿瘤患者中,保乳术后87.1%、全乳切除术后54.2%接受放疗。
  • 放疗对健康相关生活质量(乳房症状、疲劳)的影响为暂时性,18个月内消退。

核心结论

  • ≥70岁早期乳腺癌患者放疗使用受年龄和复发风险影响,老年评估参数影响有限,且放疗对健康相关生活质量影响短暂。

研究设计与样本

  • 多中心观察性队列研究,纳入2013-2018年56个英国中心2811例≥70岁接受保乳手术或全乳切除术的早期乳腺癌患者,中位随访52个月。

主要发现

  • 多因素分析显示年龄和肿瘤风险预测放疗使用。
  • 健康老年高危肿瘤患者中,保乳术后534/613(87.1%)、全乳切除术后185/341(54.2%)接受放疗。
  • 较不健康低危肿瘤保乳术后患者中,149/207(72.0%)接受放疗。
  • 放疗对健康相关生活质量 domains(包括乳房症状和疲劳)的影响在18个月内消退。

关键数值与推荐

  • 健康老年高危肿瘤患者保乳术后放疗比例87.1%,全乳切除术后54.2%。
  • 较不健康低危肿瘤患者保乳术后放疗比例72.0%。

临床怎么用

  • 老年早期乳腺癌放疗决策需综合年龄、肿瘤复发风险和老年评估,并关注治疗对生活质量的短暂影响。

局限性

  • 观察性设计可能存在混杂,老年评估参数对放疗使用影响有限,且存在地理差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiotherapy reduces in-breast recurrence risk in early breast cancer (EBC) in older women. This benefit may be small and should be balanced against treatment effect and holistic patient assessment. This study described treatment patterns according to fitness and impact on health-related quality-of-life (HRQoL). METHODS: A multicentre, observational study of EBC patients aged ≥ 70 years, undergoing breast-conserving surgery (BCS) or mastectomy, was undertaken. Associations between radiotherapy use, surgery, clinico-pathological parameters, fitness based on geriatric parameters and treatment centre were determined. HRQoL was measured using the European Organisation for the Research and Treatment of Cancer (EORTC) questionnaires. RESULTS: In 2013-2018 2811 women in 56 UK study centres underwent surgery with a median follow-up of 52 months. On multivariable analysis, age and tumour risk predicted radiotherapy use. Among healthier patients (based on geriatric assessments) with high-risk tumours, 534/613 (87.1%) having BCS and 185/341 (54.2%) having mastectomy received radiotherapy. In less fit individuals with low-risk tumours undergoing BCS, 149/207 (72.0%) received radiotherapy. Radiotherapy effects on HRQoL domains, including breast symptoms and fatigue were seen, resolving by 18 months. CONCLUSION: Radiotherapy use in EBC patients ≥ 70 years is affected by age and recurrence risk, whereas geriatric parameters have limited impact regardless of type of surgery. There was geographical variation in treatment, with some fit older women with high-risk tumours not receiving radiotherapy, and some older, low-risk, EBC patients receiving radiotherapy after BCS despite evidence of limited benefit. The impact on HRQoL is transient.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Battisti NML, Hatton MQ, Reed MWR, et al. Observational cohort study in older women with early breast cancer: Use of radiation therapy and impact on health-related quality of life and mortality. Radiother Oncol. 2021. PMID: 34146616. doi:10.1016/j.radonc.2021.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。